Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20178597

A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer : long-term survival analysis

Author
FRUSCIO, R1 ; COLOMBO, N2 ; LISSONI, A. A1 ; GARBI, A1 ; FOSSATI, R3 ; LEDA, N1 ; TORRI, V3 ; MANGIONI, C1
[1] Clinica Ostetrica e Ginecologica, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy
[2] European Institute of Oncology, University of Milan-Bicocca, Milan, Italy
[3] Department of Oncology, Mario Negri Institute for Pharmacological Research, Milan, Italy
Source

British journal of cancer. 2008, Vol 98, Num 4, pp 720-727, 8 p ; ref : 1 p.1/2

CODEN
BJCAAI
ISSN
0007-0920
Scientific domain
Medical oncology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
epirubicin first-line chemotherapy ifosfamide long-term survival ovarian cancer triplets
Keyword (fr)
Anticancéreux Cancer de l'ovaire Cancérologie Carcinome de l'ovaire Cisplatine Epirubicine Essai clinique phase II Ifosfamide Long terme Paclitaxel Randomisation Stade avancé Stade précoce Survie Traitement de première intention Triplés Agent alkylant Anthracyclines Antimitotique Cancer Dérivé de l'oxazaphosphinane Dérivé du taxane Moutarde à l'azote Pathologie de l'appareil génital femelle Pathologie des ovaires Platine II Complexe Tumeur maligne
Keyword (en)
Antineoplastic agent Ovary cancer Cancerology Ovary carcinoma Cisplatin Epirubicin Phase II trial Ifosfamide Long term Paclitaxel Randomization Advanced stage Early stage Survival First line treatment Triplets Alkylating agent Anthracyclins Antimitotic Cancer Oxazaphosphinane derivatives Taxane derivatives Nitrogen mustard Female genital diseases Ovarian diseases Platinum II Complexes Malignant tumor
Keyword (es)
Anticanceroso Cáncer del ovario Cancerología Carcinoma de ovario Cisplatino Epirubicina Ensayo clínico fase II Ifosfamida Largo plazo Paclitaxel Aleatorización Estadio avanzado Estadio precoz Sobrevivencia Tratamiento de primera línea Agente alquilante Antraciclinas Antimitótico Cáncer Oxazafosfinano derivado Taxane derivado Mostaza al nitrógeno Aparato genital hembra patología Ovario patología Platino II Complejo Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20C Female genital diseases / 002B20C02 Tumors

Discipline
Gynecology. Andrology. Obstetrics Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20178597

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web